VALLON PHARMACEUTICALS INC's ticker is VLON and the CUSIP is 92023M101. A total of 14 filers reported holding VALLON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,799 | +129883.3% | 21,569 | 0.0% | 0.00% | – |
| Q4 2022 | $6 | -99.9% | 21,569 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -53.8% | 21,569 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | -67.5% | 21,569 | 0.0% | 0.00% | – |
| Q1 2022 | $40,000 | -62.3% | 21,569 | +20.9% | 0.00% | – |
| Q4 2021 | $106,000 | -39.4% | 17,841 | -26.1% | 0.00% | – |
| Q3 2021 | $175,000 | +146.5% | 24,134 | +84.0% | 0.00% | – |
| Q2 2021 | $71,000 | – | 13,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 15 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,569 | $13,000 | 0.00% |
| CITIGROUP INC | 6,000 | $4,000 | 0.00% |
| North Star Investment Management Corp. | 1,750 | $1,000 | 0.00% |
| MORGAN STANLEY | 50 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 35,798 | $23,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,040 | $8,000 | 0.00% |
| Renaissance Technologies | 78,888 | $50,000 | 0.00% |
| VANGUARD GROUP INC | 23,464 | $15,000 | 0.00% |